Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/1999
08/12/1999CA2318857A1 Use of heregulin as an epithelial cell growth factor
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/11/1999EP0934944A1 7-bromo- and 7,7-dibromo-cepham and cephem derivatives and their use as protease inhibitors
08/11/1999EP0934745A1 Use of androsterone derivatives for inhibiting DNA binding of ap-1 and airway smooth muscle proliferation
08/11/1999EP0934341A1 Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934320A1 Naphthyridine derivatives
08/11/1999EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999EP0934304A1 2-pyrimidineamine derivatives and processes for their preparation
08/11/1999EP0934293A1 Novel compounds and compositions for treating diseases associated with tryptase activity
08/11/1999EP0934280A1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives
08/11/1999EP0934271A1 Substituted arylalkylamines as neurokinin antagonists
08/11/1999EP0934068A1 Compounds and methods
08/11/1999CN1225589A Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its prodn. and its use
08/11/1999CN1225360A Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/11/1999CN1225268A Clinical medicinal prepns. contg. flavongly coside extracted for persimmon leaves, and process for preparing same
08/10/1999US5936065 CS-1 peptidomimetics, compositions and methods of using the same
08/10/1999US5935929 Methods for treating interstitial lung disease by using interleukin-9 and its antagonists
08/10/1999US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo.
08/10/1999US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935565 Method for increasing the level of stem cells in peripheral blood
08/10/1999US5935555 Pharmaceutical formulations for treating cystic fibrosis
08/10/1999CA2126863C Chimeric immunogens
08/09/1999CA2245999A1 Novel compounds
08/05/1999WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999WO1999038877A2 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
08/05/1999WO1999038873A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038854A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038853A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999WO1999038843A1 Hydroxamic and carboxylic acid derivatives
08/05/1999WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999WO1999038510A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999WO1999038505A1 Compositions for prevention and treatment of cold and influenza-like symptoms associated with respiratory tract infections
08/05/1999WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51
08/05/1999WO1999024398A3 Urea derivatives and their use as integrin inhibitors
08/05/1999WO1999009186A3 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
08/05/1999CA2319629A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999CA2318830A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999CA2318817A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999CA2318814A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999CA2318278A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/04/1999EP0933373A1 Terpenoid lactone compounds and their production process
08/04/1999EP0933366A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
08/04/1999EP0932626A1 G protein-coupled receptor antagonists
08/04/1999EP0932397A2 Medicinal aerosol formulations comprising budesonide
08/04/1999EP0759027B1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
08/04/1999EP0752985B1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
08/04/1999EP0692970B1 Use of actin-binding compounds for the manufacture of a medicament for reducing the viscosity of pathological mucoid airway contents in the respiratory tract
08/04/1999CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors
08/04/1999CN1224720A Tetracylic derivatives, process of preparation and use
08/03/1999US5932737 Peptide compounds for treatment of no-mediated diseases
08/03/1999US5932730 Endothelin antagonist
08/03/1999US5932728 Antihistamines; antiallergens
08/03/1999US5932701 ribA
08/03/1999US5932607 Imidazole derivatives and process for preparing the same
08/03/1999US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
08/03/1999US5932589 Oral drug
08/03/1999US5932581 Administering sorbitol dehydrogenase inhibitor
08/03/1999US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions
08/03/1999US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
08/03/1999US5932560 Treatment of conditions and disease
08/03/1999US5932247 Microcrystalline cellulose, lactose and pregelatinized starch; gelatin; croscarmellose sodium
08/03/1999US5932241 Cationic lipid DNA complexes for gene targeting
07/1999
07/29/1999WO1999037760A1 Inhibition of cytokine production
07/29/1999WO1999037668A1 Thrombin inhibitors
07/29/1999WO1999037651A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037642A1 Spiropiperidine derivatives
07/29/1999WO1999037639A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
07/29/1999WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof
07/29/1999WO1999037619A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037617A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
07/29/1999WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins
07/29/1999WO1999030695A8 Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease
07/29/1999WO1999015183A9 PROTEASOME INHIBITORS, UBIQUITIN PATHWAY INHIBITORS OR AGENTS THAT INTERFERE WITH THE ACTIVATION OF NF-λB VIA THE UBIQUITIN PROTEASOME PATHWAY TO TREAT INFLAMMATORY AND AUTOIMMUNE DISEASES
07/29/1999CA2319077A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2318361A1 Spiropiperidine derivatives
07/29/1999CA2318263A1 Method for treating inflammatory diseases using heat shock proteins
07/29/1999CA2318100A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2318088A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2317839A1 Inhibition of cytokine production
07/29/1999CA2317761A1 Thrombin inhibitors
07/28/1999EP0931156A2 Gene expression and delivery systems and uses
07/28/1999EP0931087A1 Novel pyranoside derivatives
07/28/1999EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use
07/28/1999EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
07/28/1999EP0931063A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
07/28/1999EP0705265B1 Novel chemical compounds having pde-iv inhibition activity
07/28/1999EP0678122B1 Recombinant anti-vla4 antibody molecules
07/28/1999CN1224351A Pharmaceutical preparation contg. nimesulide for oral administration
07/28/1999CN1224347A High dose liposomal aerosol formulations
07/27/1999US5929236 2-substituted morpholine and thiomorpholine derivatives as GABA-B antagonists
07/27/1999US5929117 Immunotherapeutic agents
07/27/1999US5929100 Biologically active benzothiazolone ethanamines
07/27/1999US5929074 Vsodilator, antiallergic and antiplatelet agents
07/27/1999US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound
1 ... 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 ... 878